Manufacturer
PHARMANIAGA MANUFACTURING BERHAD
Contents
LAMIVUDINE
Indication
HIV infection and Chronic hepatitis B.
Instruction
May be taken with or without food
Drug interaction
Decreased renal excretion w/ high-dose trimethoprim. Severe anaemia may occur when used concomitantly w/ zidovudine. Treatment failure and emergence of resistance may result from once daily triple regimens of lamivudine and tenofovir w/ either abacavir or didanosine. May antagonise the antiviral action of zalcitabine. May enhance the adverse effect of emtricitabine.
Malaysia
